Skip to content

eFast Diagnosis Performance in Guiding First Aid Resuscitation

eFast Diagnosis Performance in Guiding First Aid Resuscitation at the Admission of Severe Trauma Injuries

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03699670
Acronym
eFAST Decision
Enrollment
510
Registered
2018-10-09
Start date
2018-07-03
Completion date
2020-01-21
Last updated
2022-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

eFast Diagnosis Performance in Guiding First Aid Resuscitation and Hemostasis

Keywords

Resuscitation, Wounds and Injuries, Ultrasonography, Radiography, Diagnostic Imaging

Brief summary

A lesion work-up associating clinical examination, extended focused ultrasound (eFAST including abdominal ultrasound \[right upper, left upper, and suprapubic quadrant\], bilateral anterior and lateral pleuropulmonary ultrasound, sub-xyphoid pericardial ultrasound, transcranial Doppler), and possibly chest and pelvis x-ray, can early diagnose the most severe traumatic lesions and guide first aid resuscitation and haemostasis. The protocol does not modify the diagnostic and therapeutic strategies applied in the participant centers. The objective of the study is to evaluate the diagnosis performance of an initial lesion assessment by extended focused ultrasound (eFAST) (possibly associated with chest and pelvis x-ray) at the early phase of a severe trauma patient care in guiding first aid resuscitation and haemostasis. The relevance will be judged on the therapeutic decisions taken (thoracic or pericardial drainage, thoracotomy or laparotomy, pelvic embolization, posture of a pelvic girdle, and early optimization of cerebral perfusion pressure) based on the initial ultrasound scan.

Detailed description

Some of the severe traumatized patients who arrive alive in the hospital, are in serious hemodynamic and / or respiratory instability and need resuscitation and / or hemostasis immediate act before a complete exhaustive work-up can be realized. Usually this is a whole body CT scan. These gestures are guided by imaging examinations (extensive focused ultrasound \[eFAST\] +/- chest X-ray +/- pelvis X-ray) which are less accurate but faster at the patient's bedside. The ability of extended focused ultrasound to properly guide immediate resuscitation and hemostasis should be evaluated to assess effectiveness and safety of the method. This trial is a national prospective cohort (6 French centers). Each participant will benefit from an initial lesion work-up by clinical examination, followed by an extended focused ultrasound (eFAST including abdominal ultrasound \[right upper, left upper, and suprapubic quadrant\], bilateral anterior and lateral pleuropulmonary ultrasound, sub-xyphoid pericardial ultrasound, transcranial Doppler), and possibly chest and pelvis frontal x-ray. Based on clinical, radiographic and ultrasound data, the investigator will decide to perform immediate resuscitation and haemostasis gestures, or therapeutic abstention, before the realization of the complete lesion work-up by whole body CT scan. This study could validate and strengthen the place of ultrasound in the initial severe traumatic patients' care and seems to be the continuity of the Peytel et al. research, studying new modalities of the eFAST. Our study could extend the scope and the conclusions of the Peytel et al. study to what is routinely done in the French and European Trauma Centers.

Interventions

None listed

Sponsors

Société Française d'Anesthésie et de Réanimation
CollaboratorOTHER
University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Serious trauma (Grade A or B according to the TRENAU classification) * In the emergency room of an investigator center

Exclusion criteria

* Patient died on site or on arrival at the emergency room * Patient with penetrating trauma * Patient admitted to another center and then transferred to an investigator center * Patient referred to in Articles L1121-5 to L1121-8 of the French Code of Public Health (pregnant, parturient, breastfeeding woman, person deprived of liberty, person under legal protection).

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the diagnosis performance of an initial lesion assessment by extended focused ultrasound (eFAST) at the early phase of a severe trauma patient care in guiding first aid resuscitation and haemostasis.Through study completion, an average of 1 yearRetrospective assessment (on whole-body CT scans data and clinical data), by a panel of experts on the legitimacy of urgent therapeutic decisions taken, following the initial injury evaluation (among a pre-selection of decisions). Assessment of presence of pericardic, intra-abdominal or pleural effusion and presence of pubic symphisis. Assessment of physiological parameters of transcranial Doppler.

Secondary

MeasureTime frameDescription
Evaluation of the duration of the initial lesion assessment by extended focused ultrasound (eFAST).A Day 0Time measured between the arrival of the patient in the emergency room and the realization of immediate gestures of resuscitation and haemostasis
Analysis of the main outcome measure in separate criterion: US (+/- Rx).Through study completion, an average of 1 yearAnalysis of the relevance of ultrasound vs X-rays by assessing the concordance rate between urgent therapeutic decisions and expert evaluations for each of the therapeutic modalities, taken separately
Comparison of observed mortality and predicted mortality assessed by ISS scoreduring patient's care, at Hour 24 and at Day 8Prognostic score ISS
Comparison of observed mortality and predicted mortality assessed by TRISSduring patient's care, at Hour 24 and at Day 8Prognostic score TRISS
Comparison of observed mortality and predicted mortality assessed by mortality evaluationduring patient's care, at Hour 24 and at Day 8Mortality evaluation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026